Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000882796-08-000015
Filing Date
2008-05-23
Accepted
2008-05-23 10:58:41
Documents
1
Period of Report
2008-05-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT doc.html 4  
1 PRIMARY DOCUMENT doc.xml 4 3829
  Complete submission text file 0000882796-08-000015.txt   5628
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Issuer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 667 MADISON AVE 17TH FLOOR NEW YORK NY 10021
Business Address 212 521 2305
Biggar Stephen R (Reporting) CIK: 0001340380 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-23186 | Film No.: 08856771